Dialysis Population Has Excess Cancer Mortality
Patients on dialysis die from cancer at twice the rate as those of the same age and sex in the general population, a study found.
Kidney Cancer
Imaging Response to Immunotherapy Combination Therapies in mRCC
Investigators report findings from the largest analysis characterizing objective imaging response among patients with mRCC treated in routine clinical practice.
Adjuvant Everolimus Appears Beneficial in Very High-Risk Kidney Cancer
Everolimus improved recurrence-free survival in patients with very high-risk disease but not in those with intermediate high-risk disease.
Immune Checkpoint Inhibitors May Aggravate Proteinuria in mRCC
In a study of patients with mRCC, both TKI and PD-1 inhibitors displayed significant nephrotoxicity.
HRQOL Data Support First-Line Lenvatinib-Pembrolizumab in Advanced Renal Cell Carcinoma
The median time to definitive deterioration was longer with lenvatinib-pembrolizumab than with sunitinib.
Guideline Updated for Use of Radiation for Brain Metastases
Updated guideline discusses advanced radiation therapy techniques and places emphasis on multidisciplinary care
Robotic Partial Nephrectomy Outcomes Worse When PSMs Are Present
Positive surgical margins in patients undergoing robotic partial nephrectomy for renal tumors are associated with adverse oncologic outcomes, a study revealed.
Neoadjuvant Axitinib May Enable Partial Nephrectomy in Complex Renal Tumors
An interim analysis suggests that axitinib given to patients with complex clear cell renal cell carcinoma tumors significantly reduces tumor size and complexity.
Morbid Obesity Ups Odds of Multiple Urologic Conditions
Efforts to reduce obesity may cut the prevalence of these urological conditions.
Black vs White Race Tied to Worse Survival in Renal Cell Carcinoma
While socioeconomic disparities are evident, survival differences between racial groups persist after RCC diagnosis.
- Loading...
Loading...
Next post in AUA 2022 Annual Meeting
Loading... 
Loading...